Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults
This study has been completed.
Study NCT00697853   Information provided by GlaxoSmithKline

First Received on June 12, 2008.   Last Updated on June 13, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial